LCZ696 matching placebo

DRUG2 trials

Sponsors

Novartis Pharmaceuticals

Conditions

Erectile DysfunctionHeart FailureHeart Failure, SystolicHypertension

Phase 2

Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

CompletedNCT01692301

Novartis PharmaceuticalsHypertension

Start: 2012-12-31End: 2015-04-30Updated: 2016-05-04

Phase 3

COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure

CompletedNCT03917459

Novartis PharmaceuticalsErectile Dysfunction, Heart Failure, Heart Failure, Systolic

Start: 2019-04-16End: 2021-05-25Updated: 2024-02-29

Related Papers

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study

BMJ Open2014-02-0151 citations